cirrhosis - Nursing Case Study
Pathophysiology
• Primary mechanism: Chronic liver injury leads to persistent inflammation and activation of hepatic stellate cells, resulting in excessive deposition of fibrous tissue and distortion of hepatic architecture. This fibrosis disrupts normal liver function and blood flow, creating a nodular liver surface.
• Secondary mechanism: Progressive fibrosis increases intrahepatic vascular resistance, leading to portal hypertension. This elevated pressure in the portal venous system causes collateral circulation, varices, and contributes to splenomegaly and ascites due to increased hydrostatic pressure and decreased oncotic pressure.
• Key complication: Portal hypertension and impaired synthetic function culminate in severe complications such as variceal bleeding, hepatic encephalopathy due to ammonia buildup, and hepatorenal syndrome, reflecting both mechanical and functional failures of cirrhotic liver adaptation.
Patient Profile
Demographics:
56-year-old male, retired construction worker
History:
• Key past medical history: Chronic alcohol abuse, hepatitis C infection, non-alcoholic steatohepatitis (NASH)
• Current medications: Furosemide, Spironolactone, Lactulose, Propranolol, Vitamin K
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Abdominal pain and severe fatigue
• Key symptoms: Ascites, jaundice, confusion, hematemesis, peripheral edema
• Vital signs: Blood pressure 90/60 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 38.3°C (100.9°F)
Section 1
As the medical team conducts the initial assessment, they are immediately concerned with the patient's hemodynamic instability and signs of respiratory distress. The patient exhibits significant confusion, consistent with hepatic encephalopathy. His abdomen is distended, with visible shifting dullness upon percussion, indicating severe ascites. The jaundice is pronounced, with scleral icterus and a deep yellow hue to the skin. Peripheral edema is noted in both lower extremities, extending up to the knees. His vital signs reveal hypotension (90/60 mmHg) and tachycardia (110 bpm), suggesting possible hypovolemia or septic shock. The elevated respiratory rate (24 breaths per minute) and low oxygen saturation (88% on room air) raise concerns for potential respiratory compromise, possibly due to ascitic fluid exerting pressure on the diaphragm.
Laboratory results return, providing further insight into the severity of the patient's condition. The complete blood count shows anemia (hemoglobin 9.5 g/dL), likely secondary to chronic disease and acute blood loss from hematemesis. The white blood cell count is elevated at 15,000/mm³, indicating possible infection, while the platelet count is low at 70,000/mm³, consistent with splenomegaly and liver dysfunction. Liver function tests show markedly elevated bilirubin (total bilirubin 6.5 mg/dL), with low albumin (2.1 g/dL) and elevated INR (2.4), reflecting impaired synthetic function. Renal function tests indicate a rising creatinine level (2.1 mg/dL), suggestive of developing hepatorenal syndrome. Arterial blood gases reveal a mixed metabolic acidosis with respiratory alkalosis, which may be due to both renal impairment and compensatory hyperventilation.
Given these findings, the team must prioritize interventions to stabilize the patient's hemodynamics and address potential complications such as variceal bleeding and infection. The decision is made to initiate broad-spectrum antibiotics to cover possible spontaneous bacterial peritonitis, a common and life-threatening complication in patients with cirrhosis and ascites. Additionally, the patient is started on intravenous albumin to improve oncotic pressure and renal perfusion, while close monitoring for renal function deterioration is maintained. The next steps in management will focus on the stabilization of vital signs, prevention of further decompensation, and addressing the underlying causes of his hepatic decline. This critical juncture poses key questions: Will the interventions halt the progression of hepatorenal syndrome, and how might the team further optimize care to prevent additional complications such as sepsis or respiratory failure?
Section 2
As the medical team closely monitors the patient over the next several hours, they observe a concerning change in his status that demands immediate attention. Despite the initiation of broad-spectrum antibiotics and intravenous albumin, the patient's condition worsens. His respiratory distress becomes more pronounced, with an increased respiratory rate of 28 breaths per minute and oxygen saturation dropping to 85% on room air. The team decides to administer supplemental oxygen and considers the need for non-invasive ventilation to support his breathing. Additionally, his mental status deteriorates further, with increased confusion and agitation, suggestive of worsening hepatic encephalopathy. The decision is made to administer lactulose to help reduce the ammonia levels contributing to his encephalopathy.
Laboratory results reveal an alarming trend: the patient's creatinine has risen to 3.0 mg/dL, indicating a progression of hepatorenal syndrome. The patient begins to exhibit signs of oliguria, with urine output falling to less than 400 mL over the past 24 hours. Given the risk of further renal impairment, the team debates the initiation of terlipressin and additional albumin in an attempt to improve renal perfusion and reverse the decline in kidney function. Meanwhile, the elevated white blood cell count persists, and a repeat abdominal ultrasound confirms the presence of free fluid, raising the suspicion of persistent or worsening spontaneous bacterial peritonitis despite antibiotic therapy.
The team is now faced with critical decisions: how to optimize renal support in the face of advancing hepatorenal syndrome, and how to effectively manage the respiratory compromise that threatens to escalate to respiratory failure. The complexity of the patient's condition underscores the need for vigilant monitoring and prompt adjustments to the therapeutic regimen to prevent further decompensation. As these interventions are considered, the team remains acutely aware of the delicate balance required to stabilize this fragile patient while minimizing the risk of additional complications such as sepsis or multi-organ failure.
Section 3
As the team proceeds with their plan to address the patient's respiratory and renal challenges, a new complication arises, heightening the urgency of the situation. Despite the administration of supplemental oxygen and the consideration for non-invasive ventilation, the patient's respiratory status deteriorates further. His respiratory rate escalates to 32 breaths per minute, and his oxygen saturation remains critically low, hovering around 82% even with high-flow oxygen. Auscultation reveals diminished breath sounds bilaterally with scattered crackles, suggesting the development of pulmonary edema, a possible consequence of worsening heart failure secondary to fluid overload and the systemic effects of cirrhosis.
In parallel, repeat laboratory tests return with concerning results. The patient's liver function tests demonstrate a significant decline, with a total bilirubin level now at 6.5 mg/dL and an INR of 2.5, indicating a further compromise in synthetic liver function. A new arterial blood gas analysis shows a pH of 7.28, pCO2 of 55 mmHg, and HCO3 of 22 mmol/L, confirming a mixed respiratory acidosis compounded by metabolic components, likely exacerbated by the patient's impaired hepatopulmonary function and renal status.
The multidisciplinary team urgently reconvenes to address these escalating issues, prioritizing the stabilization of the patient's respiratory function. The potential need for intubation and mechanical ventilation is weighed against the risk of further hemodynamic instability. Meanwhile, discussions on renal replacement therapy options, such as continuous venovenous hemofiltration (CVVH), are initiated to address the advancing hepatorenal syndrome and fluid overload contributing to his pulmonary compromise. The team's approach underscores the critical need for precise clinical judgment and coordination to navigate the intricate interplay of the patient's multisystem decline, aiming to mitigate the risk of cascading into sepsis and potential multi-organ failure.
Section 4
As the team deliberates over the immediate need for intubation, the patient suddenly becomes increasingly agitated and confused, a sign of worsening hepatic encephalopathy due to the elevated ammonia levels secondary to liver failure. His Glasgow Coma Scale (GCS) score drops to 10, reflecting a significant decline in his neurological status. This alteration necessitates a rapid reassessment of the airway management strategy, balancing the risks of intubation against the patient's deteriorating mental status and potential for airway compromise.
Simultaneously, new diagnostic imaging results return, revealing significant ascites and pleural effusions, further complicating the patient's respiratory mechanics and contributing to his hypoxemic state. The presence of large volumes of fluid in the abdominal and thoracic cavities raises the question of whether therapeutic paracentesis or thoracentesis might alleviate some of the respiratory burden. However, the patient's elevated INR poses a substantial bleeding risk, demanding careful consideration and possibly the administration of fresh frozen plasma before any invasive procedures.
Given these findings, the team makes the critical decision to proceed with intubation to protect the airway and ensure adequate oxygenation, while simultaneously preparing for renal replacement therapy to address the worsening renal function and fluid overload. The balance of aggressive intervention with careful monitoring for complications such as bleeding or infection becomes paramount, as the team works to stabilize the patient and prevent further deterioration into septic shock or multi-organ failure. This pivotal moment exemplifies the need for advanced critical thinking and seamless coordination among the multidisciplinary team, as each decision carries profound implications for the patient's survival and potential recovery.
Section 5
As the team moves swiftly to secure the airway through intubation, the patient is sedated and ventilated. Post-intubation, the initial ventilator settings are carefully adjusted to optimize oxygenation, given the patient's compromised respiratory status due to the pleural effusions and ascites. The respiratory therapist notes that despite maximum supportive measures, the patient's oxygen saturation remains marginally low at 88%, suggesting ongoing respiratory compromise. Meanwhile, the ICU nurse monitors the patient's cardiovascular status closely, noting a heart rate of 110 beats per minute and a blood pressure of 95/60 mmHg, indicating potential hemodynamic instability.
Simultaneously, laboratory results return with a markedly elevated serum creatinine of 3.5 mg/dL, further confirming acute kidney injury likely secondary to hepatorenal syndrome, a complication often seen in severe liver disease. The patient's INR is 2.5, reflecting the increased risk of bleeding, complicating the decision to perform procedural interventions. In response to these findings, the nephrology team prepares for continuous renal replacement therapy (CRRT) to manage the fluid overload and support renal function, while the hepatology team deliberates the administration of fresh frozen plasma to correct coagulopathy before any invasive interventions such as paracentesis or thoracentesis are attempted.
Meanwhile, the patient's family is briefed about the critical nature of his condition, with the multidisciplinary team involving them in discussions about the goals of care and possible outcomes. The family expresses concern over the rapid progression of the illness and seeks reassurance about the next steps. This crucial moment underscores the importance of empathetic communication and shared decision-making as the team navigates the complex interplay of multiple organ failures, balancing aggressive interventions with realistic expectations. The focus remains on stabilizing the patient, preventing further complications, and continually reevaluating the treatment plan as new clinical data emerges.